Department of Physiology, Biochemistry and Pharmacology, Faculty of Veterinary Medicine, King Faisal University, Alhofuf, 31982 Alahsa, Saudi Arabia; Department of Pharmacology, Faculty of Veterinary Medicine, Kafrelshikh University, Kafrelshikh 33516, Egypt.
Department of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University, Japan; Department of Applied Chemistry, Faculty of Engineering, Aichi Institute of Technology, Yachigusa 1247, Yakuza, Toyota 470-0392, Japan.
Int J Biol Macromol. 2018 Feb;107(Pt B):2566-2573. doi: 10.1016/j.ijbiomac.2017.10.145. Epub 2017 Oct 25.
RNA interference (RNAi) constitutes a major target in drug discovery. Recently, we reported that the Argonaute protein 2 (Ago2) PAZ domain selectively binds with all ribonucleotides except adenine and poorly recognizes deoxyribonucleotides. The binding properties of the PAZ domain with polynucleotides and the molecular mechanisms of substrates' selectivity remains unclear. In this study, the binding potencies of polynucleotides and the associated conformational and dynamic changes in PAZ domain are investigated. Coinciding with nucleotides' binding profile with the PAZ domain, polyuridylate (PolyU) and polycytidylate (PolyC) were potent binders. However, K and K were 15.8 and 9.3μM, respectively. In contrast, polyadenylate (PolyA) binding was not detectable. Molecular dynamics (MD) simulation revealed the highest change in root mean square deviation (RMSD) with ApoPAZ or PAZ domain bound with experimentally approved, low affinity substrates, whereas stronger binding substrates such as UMP or PolyU showed minimal RMSD changes. The loop between α3 and β5 in the β-hairpin subdomain showed the most responsive change in RMSD, being highly movable in the ApoPAZ and PAZ-AMP complex. Favorable substrate recognition was associate with moderate change in secondary structure content. In conclusion, the PAZ domain retains differential substrate selectivity associated with corresponding dynamic and structural changes upon binding.
RNA 干扰 (RNAi) 是药物发现的主要目标。最近,我们报道 Argonaute 蛋白 2 (Ago2) 的 PAZ 结构域选择性地与除腺嘌呤以外的所有核糖核苷酸结合,并且对脱氧核糖核苷酸的识别能力较差。PAZ 结构域与多核苷酸的结合特性以及底物选择性的分子机制仍不清楚。在这项研究中,我们研究了 PAZ 结构域与多核苷酸的结合能力以及相关的构象和动态变化。与 PAZ 结构域的核苷酸结合特征一致,多聚尿嘧啶核苷酸 (PolyU) 和多聚胞嘧啶核苷酸 (PolyC) 是有效的结合物。然而,K 和 K 分别为 15.8 和 9.3μM。相比之下,多聚腺苷酸 (PolyA) 的结合则无法检测到。分子动力学 (MD) 模拟显示,与实验证实的低亲和力底物结合时,ApoPAZ 或 PAZ 结构域的均方根偏差 (RMSD) 变化最大,而与强结合底物如 UMP 或 PolyU 结合时,RMSD 变化最小。β发夹亚结构域中α3 和β5 之间的环在 RMSD 中显示出最大的响应变化,在 ApoPAZ 和 PAZ-AMP 复合物中具有高度的可动性。有利的底物识别与二级结构含量的适度变化相关。总之,PAZ 结构域在结合时保留了与相应的动态和结构变化相关的差异底物选择性。